Heavy Metal Basic Panel (5520) (Access Medical Labs)

22 biomarkers Sample: Urine Peer-reviewed

Biomarkers in this category

22 biomarkers · optimal ranges shown

The major tissue sites of aluminum toxicity are the nervous system, immune system, bone, liver, and red blood cells. Aluminum may also interfere with heme (porphyrin) synthesis. Consequences of aluminum toxicity are encephalopathy and abnormal speech, myoclonic jerks, convulsions, and a predisposition to osteomalacic fractures. Exposure to aluminum is ubiquitous via food, water, air and soil. Aluminum is used to produce beverage cans, cooking pots, siding, roofing, aluminum foil and airplanes. Further, it is found in antacids, buffered aspirin, food additives (especially in grains and cheeses), astringents, vaccinations, cat litter, antiperspirants, infant formula, and baking soda. Aluminum has been detected in calcium, magnesium, and phosphate salts used in parenteral solutions, and it has been found high in lung tissue as a result of tobacco and cannabis smoke inhalation. When aluminum is used in water treatment facilities, concentration in community water supplies can reach 93 µmol/L (2,500 µg/L). Though not proven as a causative agent, it is striking that the neurofibrillary tangles of neurons that characterize the brains of Alzheimer’s patients (as well as in patients with amyotrophic lateral sclerosis and Parkinson’s and Huntington’s diseases) accumulate aluminum. A study group with aluminum exposure had higher vanylmandelic and homovanillic acids in urine and were significantly different from controls on neurobehavioral tests. Aluminum replaces calcium in bone, disrupting normal osteoid formation and mineralization. Assessing copper, zinc, and iron status helps to determine a patient’s vulnerability to the toxic effects of aluminum, and appropriate elemental treatments may help to overcome aluminum toxicity. Testing for anemia is indicated in patients with high RBC, plasma, or serum aluminum. Higher plasma aluminum is seen in infants fed soy formula compared with breast-fed infants. Serum, erythrocyte, and plasma aluminum levels appear to correlate. Serum aluminum levels above 5 μmol/L (135 μg/L) are predictive of aluminum toxicity. Testing for anemia is indicated in patients with high blood levels of aluminum. High hair aluminum has been shown in aluminum toxicity and therefore, a high value in hair likely reflects a regular source of exposure and should be eliminated. Urinary aluminum can provide information about aluminum intake and has been used to monitor humans exposed to dangerous amounts of aluminum. Because aluminum is ubiquitous in the environment, contamination of a patient’s specimen with aluminum is possible when collection containers are opened in living and work environments. Desferrioxamine (DFO) is a chelator of aluminum and iron that has been used to treat acute aluminum toxicity. In fact, cases of aluminum toxicity are managed similarly to iron toxicity. DFO decreased RBC and plasma aluminum and improved hemoglobin, hematocrit, and mean cell volume in 13 patients. Chelation treatment with desferrioxamine should be handled conservatively due to the risk of inadvertently mobilizing large amounts of aluminum to the brain, which may enhance encephalopathy or a chemical interaction. The chelator, L1 (1,2-dimethyl-1,3-hydroxypyrid-4-one deferiprone or DMHP) has also been used to lower aluminum total-body burden. Ascorbate combined with DFO has been used to remove aluminum from human brain cells. Glycine has been used to help mobilize aluminum. As discussed above, it is important to assure adequate status of essential elements (calcium, iron, copper, zinc). Silicon is an antagonist of aluminum. Further testing of an aluminum-toxic patient might involve measurement of bone resorption, urinary catecholamines, oxidative stress, and even vitamin D.

Titanium in the urine can be indicative of exposure to the metal, which is found in a variety of consumer products, medical devices, pharmaceuticals, and in the workplace environment. However, it's important to note that the presence of titanium in urine doesn't necessarily indicate a health risk. Titanium is generally considered to be of low toxicity to humans, but elevated levels could suggest excessive exposure, which might warrant further investigation to understand the source and potential health implications. Medical evaluation and additional tests would be necessary to assess the significance of titanium levels in urine and to determine if there is any health risk associated with the exposure.

Sources: Widespread use in military and industry as well as nuclear power. Symptoms: - Renal damage - Lung cancer Treatment: - Avoidance - IV sodium bicarbonate - Inositol hexaphosphate (animal studies) -------------- Uranium (U) is an abundant element on earth. Its widespread use in military and industry, including nuclear power, has increased human exposure. Uranium can be ingested or inhaled and is cleared in urine rapidly, although some will pool in bone and kidney tissues. Uranium toxicity in humans leads to renal damage. Lung cancer is commonly associated with inhaled uranium. Urine can be a sensitive specimen for uranium exposure, but assessment should be undertaken promptly. Intravenous sodium bicarbonate 1.4% has been used to treat uranium toxicity and inositol hexaphosphate has been used in animal studies.